The	O
EpiDerm™	B:C0282574
3D	O
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	O
control	I:C3850080
data	O
and	O
proof	O
of	O
principle	O
studies	I:C2603343
for	O
mechanistic	O
assay	I:C1510438
adaptations	O
.	O

The	O
EpiDerm™	O
3D	B:C1511123
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	O
control	I:C3850080
data	O
and	O
proof	O
of	O
principle	O
studies	I:C2603343
for	O
mechanistic	O
assay	I:C1510438
adaptations	O
.	O

The	O
EpiDerm™	O
3D	O
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	B:C3850080
control	I:C3850080
data	O
and	O
proof	O
of	O
principle	O
studies	I:C2603343
for	O
mechanistic	O
assay	I:C1510438
adaptations	O
.	O

The	O
EpiDerm™	O
3D	O
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	O
control	I:C3850080
data	O
and	O
proof	B:C0565962
of	O
principle	O
studies	I:C2603343
for	O
mechanistic	O
assay	I:C1510438
adaptations	O
.	O

The	O
EpiDerm™	O
3D	O
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	O
control	I:C3850080
data	O
and	O
proof	O
of	O
principle	B:C2603343
studies	I:C2603343
for	O
mechanistic	O
assay	I:C1510438
adaptations	O
.	O

The	O
EpiDerm™	O
3D	O
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
:	O
Historical	O
control	I:C3850080
data	O
and	O
proof	O
of	O
principle	O
studies	I:C2603343
for	O
mechanistic	B:C1510438
assay	I:C1510438
adaptations	O
.	O

The	O
in	B:C1511123
vitro	I:C1511123
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
in	O
EpiDerm™	O
is	O
a	O
promising	O
novel	O
animal	O
alternative	I:C0003059
for	O
evaluating	O
genotoxicity	O
of	O
topically	O
applied	O
chemicals	O
.	O

The	O
in	O
vitro	I:C1511123
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
in	O
EpiDerm™	B:C0282574
is	O
a	O
promising	O
novel	O
animal	O
alternative	I:C0003059
for	O
evaluating	O
genotoxicity	O
of	O
topically	O
applied	O
chemicals	O
.	O

The	O
in	O
vitro	I:C1511123
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
in	O
EpiDerm™	O
is	O
a	O
promising	O
novel	O
animal	B:C0003059
alternative	I:C0003059
for	O
evaluating	O
genotoxicity	O
of	O
topically	O
applied	O
chemicals	O
.	O

The	O
in	O
vitro	I:C1511123
human	I:C1511123
reconstructed	I:C1511123
skin	I:C1511123
micronucleus	I:C1511123
(	I:C1511123
RSMN	I:C1511123
)	I:C1511123
assay	I:C1511123
in	O
EpiDerm™	O
is	O
a	O
promising	O
novel	O
animal	O
alternative	I:C0003059
for	O
evaluating	O
genotoxicity	O
of	O
topically	O
applied	O
chemicals	B:C0220806
.	O

It	O
is	O
particularly	O
useful	O
for	O
assessing	O
cosmetic	B:C0456611
ingredients	I:C0456611
that	O
can	O
no	O
longer	O
be	O
tested	O
using	O
in	O
vivo	I:C1515655
assays	O
.	O

It	O
is	O
particularly	O
useful	O
for	O
assessing	O
cosmetic	O
ingredients	I:C0456611
that	O
can	O
no	O
longer	O
be	O
tested	O
using	O
in	B:C1515655
vivo	I:C1515655
assays	O
.	O

It	O
is	O
particularly	O
useful	O
for	O
assessing	O
cosmetic	O
ingredients	I:C0456611
that	O
can	O
no	O
longer	O
be	O
tested	O
using	O
in	O
vivo	I:C1515655
assays	B:C1510438
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	B:C0392366
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	B:C0220905
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	B:C0011109
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	B:C1511123
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	B:C0022877
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	B:C2983608
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	B:C3850013
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	B:C0162791
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	B:C1512977
cell	I:C1512977
micronucleus	O
test	I:C0026006
.	O

To	O
advance	O
the	O
use	O
of	O
this	O
test	O
especially	O
for	O
regulatory	O
decision	O
-	I:C0011109
making	I:C0011109
,	O
we	O
have	O
established	O
the	O
RSMN	O
assay	I:C1511123
in	O
our	O
laboratory	O
according	O
to	O
Good	O
Laboratory	I:C2983608
Practice	I:C2983608
and	O
following	O
the	O
principles	O
of	O
the	O
OECD	O
test	O
guideline	I:C0162791
487	I:C0162791
in	O
vitro	O
mammalian	O
cell	I:C1512977
micronucleus	B:C0026006
test	I:C0026006
.	O

Proficiency	O
with	O
the	O
assay	B:C1510438
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	O
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	B:C0026879
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	O
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	B:C0026879
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	O
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	B:C0025519
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	O
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	B:C0243095
/	O
non-carcinogenic	O
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	B:C0243095
chemicals	O
.	O

Proficiency	O
with	O
the	O
assay	O
was	O
established	O
by	O
correctly	O
identifying	O
direct	O
-	I:C0026879
acting	I:C0026879
genotoxins	I:C0026879
and	O
genotoxins	O
requiring	O
metabolism	O
,	O
as	O
well	O
as	O
non-genotoxic	O
/	O
non-carcinogenic	O
chemicals	B:C0220806
.	O

We	O
also	O
report	B:C0684224
the	O
analysis	O
of	O
our	O
historical	O
control	I:C3850080
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	O
in	O
binucleated	O
cells	I:C0333909
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O

We	O
also	O
report	O
the	O
analysis	B:C0936012
of	O
our	O
historical	O
control	I:C3850080
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	O
in	O
binucleated	O
cells	I:C0333909
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O

We	O
also	O
report	O
the	O
analysis	O
of	O
our	O
historical	B:C3850080
control	I:C3850080
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	O
in	O
binucleated	O
cells	I:C0333909
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O

We	O
also	O
report	O
the	O
analysis	O
of	O
our	O
historical	O
control	I:C3850080
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	B:C4048301
in	O
binucleated	O
cells	I:C0333909
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O

We	O
also	O
report	O
the	O
analysis	O
of	O
our	O
historical	O
control	I:C3850080
data	O
that	O
demonstrate	O
vehicle	O
control	O
and	O
positive	O
control	O
values	O
for	O
%	O
micronuclei	O
in	O
binucleated	B:C0333909
cells	I:C0333909
are	O
in	O
the	O
ranges	O
reported	O
previously	O
.	O

Technical	O
issues	O
including	O
evaluating	O
various	O
solvents	B:C0037638
with	O
both	O
48h	O
and	O
72h	O
treatment	O
regimens	I:C0040808
were	O
investigated	O
.	O

Technical	O
issues	O
including	O
evaluating	O
various	O
solvents	O
with	O
both	O
48h	O
and	O
72h	O
treatment	B:C0040808
regimens	I:C0040808
were	O
investigated	O
.	O

For	O
the	O
first	O
time	O
,	O
mechanistic	B:C2698671
studies	I:C2698671
using	O
CREST	O
analysis	I:C0242481
revealed	O
that	O
the	O
RSMN	O
assay	I:C1510438
is	O
suitable	O
for	O
distinguishing	O
aneugens	O
and	O
clastogens	O
.	O

For	O
the	O
first	O
time	O
,	O
mechanistic	O
studies	I:C2698671
using	O
CREST	B:C0242481
analysis	I:C0242481
revealed	O
that	O
the	O
RSMN	O
assay	I:C1510438
is	O
suitable	O
for	O
distinguishing	O
aneugens	O
and	O
clastogens	O
.	O

For	O
the	O
first	O
time	O
,	O
mechanistic	O
studies	I:C2698671
using	O
CREST	O
analysis	I:C0242481
revealed	O
that	O
the	O
RSMN	B:C1510438
assay	I:C1510438
is	O
suitable	O
for	O
distinguishing	O
aneugens	O
and	O
clastogens	O
.	O

For	O
the	O
first	O
time	O
,	O
mechanistic	O
studies	I:C2698671
using	O
CREST	O
analysis	I:C0242481
revealed	O
that	O
the	O
RSMN	O
assay	I:C1510438
is	O
suitable	O
for	O
distinguishing	O
aneugens	B:C0949641
and	O
clastogens	O
.	O

For	O
the	O
first	O
time	O
,	O
mechanistic	O
studies	I:C2698671
using	O
CREST	O
analysis	I:C0242481
revealed	O
that	O
the	O
RSMN	O
assay	I:C1510438
is	O
suitable	O
for	O
distinguishing	O
aneugens	O
and	O
clastogens	B:C0008904
.	O

Moreover	O
,	O
the	O
assay	B:C1510438
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	O
as	O
markers	O
for	O
proliferative	O
and	O
toxic	O
effects	I:C0600688
of	O
chemicals	O
.	O

Moreover	O
,	O
the	O
assay	O
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	B:C0079189
as	O
markers	O
for	O
proliferative	O
and	O
toxic	O
effects	I:C0600688
of	O
chemicals	O
.	O

Moreover	O
,	O
the	O
assay	O
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	O
as	O
markers	O
for	O
proliferative	B:C0334094
and	O
toxic	O
effects	I:C0600688
of	O
chemicals	O
.	O

Moreover	O
,	O
the	O
assay	O
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	O
as	O
markers	O
for	O
proliferative	O
and	O
toxic	B:C0600688
effects	I:C0600688
of	O
chemicals	O
.	O

Moreover	O
,	O
the	O
assay	O
is	O
also	O
suitable	O
for	O
measuring	O
cytokines	O
as	O
markers	O
for	O
proliferative	O
and	O
toxic	O
effects	I:C0600688
of	O
chemicals	B:C0220806
.	O

